Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience
Titel:
Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience
Auteur:
Murthy, Rashmi K. Raghavendra, Akshara S. Hess, Kenneth R. Fujii, Takeo Lim, Bora Barcenas, Carlos H. Zhang, Hong Chavez-Mac-Gregor, Mariana Mittendorf, Elizabeth A. Litton, Jennifer K. Giordano, Sharon H. Thompson, Alastair M. Valero, Vicente Moulder, Stacy L. Tripathy, Debu Ueno, Naoto T.